Shares of YM Biosciences Inc. fell 12 percent on news that the FDA placed a clinical hold on a Phase II study of AeroLEF in acute pain. The agency, which previously cleared the company to start Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback